Cogent Biosciences, Inc. (COGT)

34.74 -0.78 (-2.21%) USD  |  NASDAQ  |  Jan 02, 16:00
34.74 0.00 (0.00%) After-Hours: 17:12
More

Cogent Biosciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Pfizer Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade